RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+5.69%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.2B
AUM Growth
+$35.4M
(+1.6%)
Cap. Flow
+$53.7M
Cap. Flow
% of AUM
2.44%
Top 10 Holdings %
Top 10 Hldgs %
26.51%
Holding
158
New
11
Increased
46
Reduced
21
Closed
14
Top Buys
| 1 |
Teleflex
TFX
|
$22.8M |
| 2 |
Stryker
SYK
|
$19.6M |
| 3 |
Hologic
HOLX
|
$14.3M |
| 4 |
Zimmer Biomet
ZBH
|
$11.8M |
| 5 |
Molina Healthcare
MOH
|
$11.1M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$28.9M |
| 2 |
Danaher
DHR
|
$19.3M |
| 3 |
Medtronic
MDT
|
$19.2M |
| 4 |
BCR
CR Bard Inc.
BCR
|
$18.4M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$12.8M |
Sector Composition
| 1 | Healthcare | 85.2% |
| 2 | Financials | 2.8% |
| 3 | Consumer Discretionary | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$102B
| $25.7M | 1.16% |
171,250
+19,750
| +13% | +$2.96M |
|
27
Exact Sciences
EXAS
$9.96B
| $22.9M | 1.04% |
434,900
-2,500
| -0.6% | -$131K |
|
|
28
Teleflex
TFX
$5.68B
| $22.8M | 1.04% |
+91,750
| New | +$22.8M |
|
29
iRhythm Technologies
IRTC
$5.85B
| $22.8M | 1.03% |
406,000
+20,000
| +5% | +$1.12M |
|
30
Gilead Sciences
GILD
$140B
| $22.5M | 1.02% |
313,400
| – | – |
|
31
Mersana Therapeutics
MRSN
$34.7M
| $21.8M | 0.99% |
53,072
-128
| -0.2% | -$52.6K |
|
32
Edwards Lifesciences
EW
$47.4B
| $21.4M | 0.97% |
570,003
| – | – |
|
33
Thermo Fisher Scientific
TMO
$184B
| $20.9M | 0.95% |
110,000
| – | – |
|
34
Assembly Biosciences
ASMB
$174M
| $20.4M | 0.92% |
37,500
+5,000
| +15% | +$2.72M |
|
|
35
Stryker
SYK
$151B
| $19.6M | 0.89% |
+126,500
| New | +$19.6M |
|
|
AVXS
36
DELISTED
AveXis, Inc. Common Stock
AVXS
| $19.4M | 0.88% |
175,000
| – | – |
|
37
Insmed
INSM
$30.1B
| $19.1M | 0.87% |
613,500
-36,500
| -6% | -$1.14M |
|
|
MDCO
38
DELISTED
Medicines Co
MDCO
| $18.9M | 0.86% |
690,000
| – | – |
|
39
Willis Towers Watson
WTW
$32B
| $18.5M | 0.84% |
123,000
+8,000
| +7% | +$1.21M |
|
40
Theravance Biopharma
TBPH
$706M
| $18.2M | 0.83% |
652,600
+8,200
| +1% | +$229K |
|
41
Galapagos
GLPG
$2.06B
| $17.3M | 0.79% |
185,000
-29,000
| -14% | -$2.72M |
|
42
Incyte
INCY
$16.7B
| $17.3M | 0.78% |
182,500
+9,500
| +5% | +$900K |
|
43
Biogen
BIIB
$20.3B
| $16.9M | 0.77% |
53,000
| – | – |
|
44
Jazz Pharmaceuticals
JAZZ
$7.77B
| $16.7M | 0.76% |
123,700
| – | – |
|
|
EPZM
45
DELISTED
Epizyme, Inc
EPZM
| $16.6M | 0.75% |
1,325,000
-25,000
| -2% | -$314K |
|
46
Alnylam Pharmaceuticals
ALNY
$59.4B
| $16.5M | 0.75% |
130,000
+25,000
| +24% | +$3.18M |
|
|
BOLD
47
DELISTED
Audentes Therapeutics, Inc
BOLD
| $16.4M | 0.74% |
525,000
| – | – |
|
|
AMRN
48
Amarin Corp
AMRN
$306M
| $15.8M | 0.72% |
197,500
-2,500
| -1% | -$201K |
|
|
PTLA
49
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $15.8M | 0.72% |
323,800
| – | – |
|
|
CLVS
50
DELISTED
Clovis Oncology, Inc.
CLVS
| $15.7M | 0.71% |
231,500
| – | – |
|